News
Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...
IPG has launched Agentic Systems for Commerce (ASC), to help brands manage the complex commerce ecosystem. To optimize commerce performance, ASC leverages Interpublic’s proprietary agentic system, ...
Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...
LG Energy Solution posts KRW 5.6 trillion in consolidated revenue and KRW 492.2 billion in operating profit in Q2 2025The company records quarterly ...
The Dividend Harvesting Portfolio hit new all-time highs, delivering a 29.44% return. Learn more about the portfolio and why ...
1d
Zacks Investment Research on MSNHere's What to Expect From Pfizer's Non-Oncology Drugs in Q2 EarningsPfizer PFE is due to report second-quarter results on Aug. 5. All eyes will be on sales of Pfizer’s oncology drugs, which ...
Opinion
3dOpinion
Zacks Investment Research on MSNEarly Q2 Results Indicate an Improving Earnings OutlookWe get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. The reporting docket expands beyond the Finance core, ...
Pfizer is on the brink of a major rebound, transitioning focus to oncology and potential blockbuster drugs after a sharp drop in COVID-related revenues. Pfizer’s stock has plummeted over 50% in the ...
Leerink Partnrs has trimmed its Q2 2025 earnings estimate for Merck & Co., Inc., foreseeing a dip to $1.96 per share from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results